Primary Basal Cell Carcinoma Masquerading as Metastatic Basal Cell Carcinoma in the Left Axilla.

alnd: - axillary lymph node dissection basal cell carcinoma diagnosis basal cell carcinoma histopathology basal cell neoplasms dermato-oncology hedgehog pathway infiltrative disease metastatic basal cell carcinoma onco dermatology positive sentinel lymph node biopsy

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Sep 2023
Historique:
accepted: 05 09 2023
medline: 9 10 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

Basal cell carcinoma (BCC) is considered the most common malignancy in Caucasians. Despite its high prevalence, BCC has extremely low rates of metastasis. The patient was a 71-year-old male with extensive BCC and squamous cell carcinoma (SCC) skin cancer history who had an extensive, palpable left axillary mass concerning enlarged lymph nodes. No skin lesions were visualized. A lymph node biopsy revealed a sclerosing/infiltrative BCC with perineural invasion extending to the inked margins of the excision and one of four lymph nodes involved by BCC through direct extension. Sectioning revealed a 3.0 x 2.8 x 2.9 cm, ill-defined, fibrotic pink-white mass within the soft tissue. Two tan to pink possible lymph nodes were also identified within the soft tissue, measuring 0.7cm and 0.9cm. There was no definite direct invasion noted, making metastatic BCC suspicious. A left axillary lymph node dissection was performed. In short, he had a nonmobile tumor that showed evidence of invasion of the adjacent pectoralis muscle near the chest wall, abutting the left axillary vein, with extension. In July 2022, approximately one year after diagnosis, the patient received a PET scan and had no remote sites of disease. Every follow-up PET scan since has shown stable disease, most recently in May 2023. The patient continues dermatology follow-ups every three months for clinical surveillance. This case is unique because metastatic disease was never confirmed, though it is still a possibility. The affected lymph nodes were in the regional basin, where the patient had had extensive skin cancers in the past. Their involvement could have been secondary to direct invasion, though this could not be confirmed histologically, making the definitive characterization of this particular tumor difficult. As the PET CT scans have remained stable without evidence of distant disease, we favor that this is a recurrent primary tumor with direct extension to the underlying pectoralis and axillary lymph nodes. As common as BCCs are, this case highlights the importance of diligent treatment and follow-up to avoid the potential for tumor-related morbidity and, rarely, mortality.

Identifiants

pubmed: 37809148
doi: 10.7759/cureus.44732
pmc: PMC10553844
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e44732

Informations de copyright

Copyright © 2023, Haskell Hanisch et al.

Déclaration de conflit d'intérêts

The authors have declared financial relationships, which are detailed in the next section.

Références

J Am Acad Dermatol. 2021 Aug;85(2):388-395
pubmed: 33852922
Case Rep Oncol Med. 2018 Apr 24;2018:3485326
pubmed: 29854516
Br J Dermatol. 2017 Aug;177(2):359-372
pubmed: 28220485
Int J Mol Sci. 2020 Aug 04;21(15):
pubmed: 32759706
JAMA Dermatol. 2013 May;149(5):541-7
pubmed: 23677079
Case Rep Med. 2017;2017:8929745
pubmed: 29279714

Auteurs

Brianne Haskell Hanisch (B)

Medical School, The University of South Dakota Sanford School of Medicine, Sioux Falls, USA.

Marcus L Frohm (ML)

Mohs Surgery, Sanford University of South Dakota Medical Center, Sioux Falls, USA.

Tamara Poling (T)

General Dermatology, Rapid City Medical Center, Rapid City, USA.

Classifications MeSH